PDF(Sci-hub)
Abstract：
Kidney transplant recipients have been reported at a particularly high risk of severe COVID-19 illness due to chronic immunosuppression and coexisting conditions. Yet, here we describe a remarkably mild case of COVID-19 in a 62-year-old female who had a kidney transplantation 10 years earlier due to autosomal dominant polycystic kidney disease. The patient was admitted for 1 day; immunosuppressive therapy with tacrolimus and low-dose prednisolone was continued; and the patient recovered successfully without the use of antiviral agents or oxygen therapy. The case demonstrates that kidney transplant recipients are not necessarily severely affected by COVID-19. Withdrawal of immunosuppressive therapy could be associated with poorer outcomes and should not be implemented thoughtlessly.
摘要：
据报道，由于慢性免疫抑制和共存疾病，肾移植受者患严重COVID-19疾病的风险特别高。然而，在这里，我们描述了一例62岁女性的COVID-19病例，该女性10年前因常染色体显性遗传性多囊肾病进行了肾脏移植。患者入院1天；继续他克莫司和低剂量泼尼松龙的免疫抑制治疗；患者在不使用抗病毒药物或氧气治疗的情况下成功康复。该病例表明，肾移植受者不一定受到COVID-19的严重影响。取消免疫抑制治疗可能与较差的预后有关，不应轻思地实施。
